1. What is anemia? Anemia refers to a common clinical symptom in which the volume of red blood cells in the peripheral blood of the human body is reduced and is lower than the limit of the normal range.

1. What is anemia? Anemia refers to a common clinical symptom in which the volume of red blood cells in the peripheral blood of the human body is reduced and lower than the limit of the normal range.

On the morning of August 30th, the Polish partners, accompanied by the leaders of the WIZ company, conducted an in-depth visit and investigation of POCT "integration of production, marketing and research", aiming to deepen mutual trust, cooperation, win-win relationship and provide better products and services for the European market.

Crossing the chilly spring in April, watching the birds flying and the grass growing in May, welcoming the colorful and lush June, and welcoming the children's own festival-the International Children’s Day. In order to let the employees and their children have an extraordinary Children's Day, WIZ company decided to hold a series of activities themed "Wizbiotech together with your children ". WIZ had invited employees’ big and small children to enjoy wonderfull moments with WIZ's deep concern and love for the children.

Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease that mainly involves the digestive system, and Crohn's disease (CD) and ulcerative colitis (UC) are the main types of it. Common complications of UC include toxic megacolon, colonic stenosis, intestinal obstruction, intestinal bleeding, intestinal perforation, colon polyps, and colon cancer; common complications of CD include fistula, abdominal abscess, intestinal obstruction, and perianal lesions, less likely to develop into a cancer.

The IVD industry refers to the in vitro diagnostic field, which by mean of the techniques such as molecular biology and biochemical analysis to detect and diagnose physiological or pathological states of the human body. With the upgrading of network technology, the digitization and intelligence in the IVD industry have been becoming as a development trend.

According to relevant data, the global market size of in vitro diagnostics in 2020 is $71.49 billion, and that of 2021 is $92.08 billion, which is expected to grow from $71.43 billion in 2022 to $107.42 billion in 2029, with a compound annual growth rate of 6% during the forecast period. During this period, the COVID-19 pandemic has increased the demand for in vitro diagnostics, and market participants have collectively witnessed a significant increase in sales and revenue from point-of-care tests.